SKP2 and chronic myelogenous leukemia, BCR-ABL1 positive: Additionally, we also evaluated the effect of Spautin-1, a selective inhibitor of USP10 and USP1345, on the activation of the Bcr-Abl-SKP2 axis and other downstream signals in human CML cells.